David Jin
2022 - Fortress Biotech
In 2022, David Jin earned a total compensation of $1.5M as Chief Financial Officer and Head of Corporate Development at Fortress Biotech.
Compensation breakdown
| Bonus | $52,500 |
|---|---|
| Salary | $338,500 |
| Stock Awards | $1,123,281 |
| Other | $33,882 |
| Total | $1,548,163 |
Jin received $1.1M in stock awards, accounting for 73% of the total pay in 2022.
Jin also received $52.5K in bonus, $338.5K in salary and $33.9K in other compensation.
Rankings
In 2022, David Jin's compensation ranked 2,128th out of 5,505 executives tracked by ExecPay. In other words, Jin earned more than 61.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,128 out of 5,505 | 61st |
Division Manufacturing | 1,144 out of 2,984 | 62nd |
Major group Chemicals And Allied Products | 491 out of 1,339 | 63rd |
Industry group Drugs | 451 out of 1,242 | 64th |
Industry Pharmaceutical Preparations | 326 out of 896 | 64th |
Source: SEC filing on April 5, 2024.
Jin's colleagues
We found two more compensation records of executives who worked with David Jin at Fortress Biotech in 2022.
News
Fortress Biotech CFO David Jin's 2023 pay jumps 267% to $1.3M
April 5, 2024
Avalon GloboCare Corp. CEO David Jin's 2022 pay stays at $360K
September 8, 2023
Avalon GloboCare Corp. CEO David Jin's 2021 pay falls 64% to $360K
November 21, 2022
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2020 pay slips 20% to $1.1M
December 13, 2021
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2019 pay rises 3% to $1.3M
June 22, 2020
Avalon GloboCare Corp. CFO Luisa Ingargiola's 2018 pay jumps 34% to $1.3M
June 17, 2019